← Back to Search

Coenzyme Q10 Supplement

Older adults with sarcopenia (drug) for Sarcopenia (COQ10 Trial)

Phase < 1
Waitlist Available
Led By Paul Coen, PhD
Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following 28 days of treatment
Awards & highlights

Summary

This trial is testing if taking CoQ10 pills can help older adults with muscle loss. The study lasts for about a month. Researchers want to see if CoQ10 improves muscle strength, aerobic capacity, and overall physical function by helping cells make more energy. Coenzyme Q10 (CoQ10) has been studied for its potential benefits in improving muscle metabolism, exercise performance, and reducing fatigue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following 28 days of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and following 28 days of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measurement of platelet CoQ10 level
Measurement of skeletal muscle

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Older adults with sarcopenia (drug)Active Control1 Intervention
Group II: Older adults with sarcopenia (placebo)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,621 Total Patients Enrolled
2 Trials studying Sarcopenia
275 Patients Enrolled for Sarcopenia
AdventHealth Translational Research InstituteLead Sponsor
48 Previous Clinical Trials
5,628 Total Patients Enrolled
2 Trials studying Sarcopenia
275 Patients Enrolled for Sarcopenia
Paul Coen, PhDPrincipal InvestigatorAdventHealth Translational Research Institute
5 Previous Clinical Trials
191 Total Patients Enrolled
1 Trials studying Sarcopenia
75 Patients Enrolled for Sarcopenia
~0 spots leftby Dec 2024